Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients
Objective: The aim of this study was to investigate factors associated with thrombosis that may contribute to recurrent pregnancy loss (habitual abortion), specifically differences in serum levels of platelet-activating factor and thrombin-activatable fibrinolysis inhibitor (carboxypeptidase B2) bet...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-02-01
|
Series: | Taiwanese Journal of Obstetrics & Gynecology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1028455915002958 |
id |
doaj-3e76acf961ef41e0b9cc3c19c5f93deb |
---|---|
record_format |
Article |
spelling |
doaj-3e76acf961ef41e0b9cc3c19c5f93deb2020-11-24T22:22:17ZengElsevierTaiwanese Journal of Obstetrics & Gynecology1028-45592016-02-01551606310.1016/j.tjog.2015.06.013Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patientsAyla Eser0Ilknur Inegol Gumus1Husamettin Erdamar2Ikbal Kaygusuz3Melahat Yildirim4Betul Usluogullari5Muzeyyen Duran Erdolu6Serap Aynur Simavli7Ramazan Yigitoglu8Nilgun Ozturk Turhan9Department of Obstetrics and Gynecology, Turgut Ozal University Medical School, Ankara, TurkeyDepartment of Obstetrics and Gynecology, Turgut Ozal University Medical School, Ankara, TurkeyDepartment of Biochemistry, Turgut Ozal University Medical School, Ankara, TurkeyDepartment of Obstetrics and Gynecology, Turgut Ozal University Medical School, Ankara, TurkeyDepartment of Obstetrics and Gynecology, Ataturk Education and Research Hospital, Ankara, TurkeyDepartment of Obstetrics and Gynecology, Cengiz Gokcek Hospital, Gaziantep, TurkeyDepartment of Obstetrics and Gynecology, Sevket Yilmaz Education and Research Hospital, Bursa, TurkeyDepartment of Obstetrics and Gynecology, Pamukkale University Medical School, Denizli, TurkeyDepartment of Biochemistry, Turgut Ozal University Medical School, Ankara, TurkeyDepartment of Obstetrics and Gynecology, Sitki Kocman University Medical School, Mugla, TurkeyObjective: The aim of this study was to investigate factors associated with thrombosis that may contribute to recurrent pregnancy loss (habitual abortion), specifically differences in serum levels of platelet-activating factor and thrombin-activatable fibrinolysis inhibitor (carboxypeptidase B2) between women with a history of recurrent miscarriage and those with no recurrent miscarriage history. Materials and methods: A case-controlled, prospective study design was adopted to compare women with a history of two or more first-trimester miscarriages (n = 42) with those with no history of recurrent miscarriage (n = 36). Participants were recruited from the Department of Obstetrics and Gynecology of Turgut Ozal University Hospital. Platelet-activating factor and thrombin-activatable fibrinolysis inhibitor levels in serum samples were measured by an enzyme-linked immunosorbent assay. Results: Platelet-activating factor levels were significantly (p = 0.018) higher in the recurrent miscarriage group. There was no difference in levels of thrombin-activatable fibrinolysis inhibitor expression between the groups. Conclusion: Platelet-activating factor is significantly higher in serum of patients with a history of recurrent miscarriage than in those without such a history, with potential implications for placental function and fetal growth, which could be relevant to miscarriage recurrence. Larger studies are indicated to further examine these findings.http://www.sciencedirect.com/science/article/pii/S1028455915002958abortionhabitualcarboxypeptidase B2platelet activating factorpregnancy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ayla Eser Ilknur Inegol Gumus Husamettin Erdamar Ikbal Kaygusuz Melahat Yildirim Betul Usluogullari Muzeyyen Duran Erdolu Serap Aynur Simavli Ramazan Yigitoglu Nilgun Ozturk Turhan |
spellingShingle |
Ayla Eser Ilknur Inegol Gumus Husamettin Erdamar Ikbal Kaygusuz Melahat Yildirim Betul Usluogullari Muzeyyen Duran Erdolu Serap Aynur Simavli Ramazan Yigitoglu Nilgun Ozturk Turhan Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients Taiwanese Journal of Obstetrics & Gynecology abortion habitual carboxypeptidase B2 platelet activating factor pregnancy |
author_facet |
Ayla Eser Ilknur Inegol Gumus Husamettin Erdamar Ikbal Kaygusuz Melahat Yildirim Betul Usluogullari Muzeyyen Duran Erdolu Serap Aynur Simavli Ramazan Yigitoglu Nilgun Ozturk Turhan |
author_sort |
Ayla Eser |
title |
Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients |
title_short |
Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients |
title_full |
Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients |
title_fullStr |
Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients |
title_full_unstemmed |
Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients |
title_sort |
levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients |
publisher |
Elsevier |
series |
Taiwanese Journal of Obstetrics & Gynecology |
issn |
1028-4559 |
publishDate |
2016-02-01 |
description |
Objective: The aim of this study was to investigate factors associated with thrombosis that may contribute to recurrent pregnancy loss (habitual abortion), specifically differences in serum levels of platelet-activating factor and thrombin-activatable fibrinolysis inhibitor (carboxypeptidase B2) between women with a history of recurrent miscarriage and those with no recurrent miscarriage history.
Materials and methods: A case-controlled, prospective study design was adopted to compare women with a history of two or more first-trimester miscarriages (n = 42) with those with no history of recurrent miscarriage (n = 36). Participants were recruited from the Department of Obstetrics and Gynecology of Turgut Ozal University Hospital. Platelet-activating factor and thrombin-activatable fibrinolysis inhibitor levels in serum samples were measured by an enzyme-linked immunosorbent assay.
Results: Platelet-activating factor levels were significantly (p = 0.018) higher in the recurrent miscarriage group. There was no difference in levels of thrombin-activatable fibrinolysis inhibitor expression between the groups.
Conclusion: Platelet-activating factor is significantly higher in serum of patients with a history of recurrent miscarriage than in those without such a history, with potential implications for placental function and fetal growth, which could be relevant to miscarriage recurrence. Larger studies are indicated to further examine these findings. |
topic |
abortion habitual carboxypeptidase B2 platelet activating factor pregnancy |
url |
http://www.sciencedirect.com/science/article/pii/S1028455915002958 |
work_keys_str_mv |
AT aylaeser levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients AT ilknurinegolgumus levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients AT husamettinerdamar levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients AT ikbalkaygusuz levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients AT melahatyildirim levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients AT betulusluogullari levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients AT muzeyyenduranerdolu levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients AT serapaynursimavli levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients AT ramazanyigitoglu levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients AT nilgunozturkturhan levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients |
_version_ |
1725769007551741952 |